Lactation Stage Influences Drug Milk-to-Serum Values and Neonatal Exposure Risk

被引:4
作者
Ling, Binbing [1 ]
Alcorn, Jane [1 ]
机构
[1] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
risk assessment; exposure index; lactation stage; active transport; pharmacokinetics; SYSTEMIC CLEARANCE PATHWAYS; CANCER RESISTANCE PROTEIN; BREAST-MILK; MAMMARY-GLAND; ACTIVE-TRANSPORT; EXPRESSION; EXCRETION; COLOSTRUM; INFANTS; PHARMACOKINETICS;
D O I
10.1177/1091581810367949
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of our study was to assess the influence of lactation stage-dependent differences in milk-to-serum (M/S) ratio for an actively transported drug (cefepime) on the calculation of 2 exposure indices, EIDose and EIConc. Age-dependent differences in cefepime pharmacokinetics at postnatal days 4 and 10 as well as cefepime M/S values at lactation days 4 and 10 in rats were determined. Significantly higher elimination rate constant and systemic clearance and lower half-life were found in day 10 compared to day 4 pups with no differences in oral bioavailability. The EIConc was quantitatively higher than EIDose at both lactation stages. The similar to 7-fold decrease in cefepime M/S values at lactation day 10 resulted in similar to 7-fold reduction in the EIDose and similar to 13-fold reduction in EIConc. Our study confirms the need to evaluate M/S at different lactation stages for actively transported drugs to avoid over- or underestimation of neonatal exposure risk.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 43 条
  • [1] Pharmacokinetics in the newborn
    Alcorn, J
    McNamara, PJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (05) : 667 - 686
  • [2] Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction
    Alcorn, J
    Lu, X
    Moscow, JA
    McNamara, PJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02) : 487 - 496
  • [3] Alcorn J, 2002, CLIN PHARMACOKINET, V41, P1077, DOI 10.2165/00003088-200241130-00005
  • [4] Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I
    Alcorn, J
    McNamara, PJ
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (12) : 959 - 998
  • [5] American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776
  • [6] CONCENTRATIONS OF THIOPENTONE IN MATURE BREAST-MILK AND COLOSTRUM FOLLOWING AN INDUCTION DOSE
    ANDERSEN, LW
    QVIST, T
    HERTZ, J
    MOGENSEN, F
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1987, 31 (01) : 30 - 32
  • [7] DRUGS IN HUMAN-MILK - CLINICAL PHARMACOKINETIC CONSIDERATIONS
    ATKINSON, HC
    BEGG, EJ
    DARLOW, BA
    [J]. CLINICAL PHARMACOKINETICS, 1988, 14 (04) : 217 - 240
  • [8] Auerbach K G, 1999, J Obstet Gynecol Neonatal Nurs, V28, P554, DOI 10.1111/j.1552-6909.1999.tb02029.x
  • [9] Colostrum morphine concentrations during Postcesarean intravenous patient-controlled analgesia
    Baka, NE
    Bayoumeu, F
    Boutroy, MJ
    Laxenaire, MC
    [J]. ANESTHESIA AND ANALGESIA, 2002, 94 (01) : 184 - 187
  • [10] Bennett PN., 1996, DRUGS HUMAN LACTATIO